Benitec Biopharma (ASX:BLT) PB Ratio : 0.55 (As of May. 21, 2024)

View and export this data going back to 1997. Start your Free Trial

What is Benitec Biopharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), Benitec Biopharma's share price is A$0.03. Benitec Biopharma's Book Value per Share for the quarter that ended in Mar. 2024 was A$0.06. Hence, Benitec Biopharma's PB Ratio of today is 0.55.

The historical rank and industry rank for Benitec Biopharma's PB Ratio or its related term are showing as below:

ASX:BLT' s PB Ratio Range Over the Past 10 Years
Min: 0.23 Med: 2.77 Max: 72.12
Current: 2.48

During the past 11 years, Benitec Biopharma's highest PB Ratio was 72.12. The lowest was 0.23. And the median was 2.77.

ASX:BLT's PB Ratio is ranked better than
51.47% of 1323 companies
in the Biotechnology industry
Industry Median: 2.53 vs ASX:BLT: 2.48

During the past 12 months, Benitec Biopharma's average Book Value Per Share Growth Rate was 47.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -90.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -56.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -50.90% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Benitec Biopharma was 86.60% per year. The lowest was -90.80% per year. And the median was -31.35% per year.

Back to Basics: PB Ratio

Benitec Biopharma PB Ratio Historical Data

The historical data trend for Benitec Biopharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benitec Biopharma PB Ratio Chart

Benitec Biopharma Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

PB Ratio

Get a 7-Day Free Trial

0.65

Benitec Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Benitec Biopharma's PB Ratio

For the Biotechnology subindustry, Benitec Biopharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Benitec Biopharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benitec Biopharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Benitec Biopharma's PB Ratio falls into.

Benitec Biopharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Benitec Biopharma's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	0.03	/	0.055
	=	0.55

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Benitec Biopharma (ASX:BLT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Benitec Biopharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Benitec Biopharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Benitec Biopharma (ASX:BLT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benitec Biopharma Inc (ASX:BLT) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

BNTC:USA

Address

3940 Trust Way, Hayward, CA, USA, 94545

Website

https://www.benitec.com

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.